Jason Hope and His Legacy of Philanthropy
Jason Hope, an internet entrepreneur based out of the Arizona area, has championed and lead the charge on anti-aging research. He is employing his own money to support initiatives focused on anti aging. Jason Hope is deeply involved on SENS Foundation, a non-profit organization addressing age related disease,s such as diabetes type 2 and Alzheimer’s disease, through state of the art research and rejuvenation biotechnology. Jason believes that we should be proactive, rather than reactive, when preventing these diseases from occurring. .
Rejuvenation biotechnology is is quickly becoming the wave of the future. It focuses on the prevention of chronic disease in order to boost the quality of life. It is an approach that is designed to create a healthier life. Researchers have found that damage caused by metabolism over a long period of time is responsible for the onset of diseases when people advance in age. Rejuvenation biotechnology aims to repair damage within the body that is caused by normal metabolism well before chronic disease has the opportunity to begin.
Diabetes Type 2 is an important example of long term affects of metabolism on the body. The destruction of insulin producing cells in the pancreas causes Type 2 diabetes to occur. As a result, blood glucose levels in the blood rise because not enough insulin is being made to assist glucose to enter the cells in the body. Glucose is a simple sugar that is converted to energy within the mitochondria of the cells. Without a consistent supply of energy being made, the symptoms of diabetes occur. These symptoms include lethargy, dry mouth, and dizzy spells. Along with these symptoms, damage to the cardiovascular and brain tissues as well as blood vessels occurs when high blood sugar is not controlled.
Mr. Hope is passionate about decreasing the number of people that are being diagnosed every year with age related diseases. He is committed to bringing about timely results that will benefit all people in the future. He has promised to support organizations that reduce disease progression through research and education.